2016
DOI: 10.2119/molmed.2016.00229
|View full text |Cite
|
Sign up to set email alerts
|

The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease

Abstract: X-box binding protein 1 (XBP1) is a unique basic region leucine zipper transcription factor that was isolated two decades ago in a search for regulators of major histocompatibility complex class II gene expression. XBP1 is a very complex protein that regulates many physiological functions, including the immune system, inflammatory responses and lipid metabolism. Evidence over the past few years suggests that XBP1 also plays an important role in pathological settings, since its activity as a transcription facto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
19
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 242 publications
(218 reference statements)
0
19
0
Order By: Relevance
“…During AD, the continuous accumulation of Aβ or p‐tau is proposed to result in abnormal levels of ER stress, contributing to synapse dysfunction and neurodegeneration . In the past 10 years, accumulating evidence supports a therapeutic potential of targeting the UPR to slow down AD in various preclinical models using pharmacological or gene therapy approaches . In this review, we discuss the latest discoveries highlighting the functional role of ER stress in AD and its impact in synaptic dysfunction and cognitive impairment.…”
Section: Introductionmentioning
confidence: 98%
“…During AD, the continuous accumulation of Aβ or p‐tau is proposed to result in abnormal levels of ER stress, contributing to synapse dysfunction and neurodegeneration . In the past 10 years, accumulating evidence supports a therapeutic potential of targeting the UPR to slow down AD in various preclinical models using pharmacological or gene therapy approaches . In this review, we discuss the latest discoveries highlighting the functional role of ER stress in AD and its impact in synaptic dysfunction and cognitive impairment.…”
Section: Introductionmentioning
confidence: 98%
“…However, under chronic or irreversible ER stress conditions, the UPR shifts its signaling toward cell death 11 . Modulation of ER-UPR has therefore been one potential therapeutic strategy for slowing down AD, using gene therapy or pharmacological approaches 12,13 .…”
mentioning
confidence: 99%
“…XBP1 occupancy was observed on the promoters of genes linked to neurodegenerative pathologies including Alzheimers disease [50], although the relevance of these events remains speculative. Indeed, XBP1 activates a plethora of target genes involved in a variety of physiological functions, including neuronal plasticity [51][50] [52], suggesting an important role during the branching and maturation of developing neurons. Accumulation of unfolded or misfolded proteins in the ER leads to an ER stress response, which is characteristic of cells with a high level of secretory activity and is implicated in a variety of disease conditions such as AD [53].…”
Section: Discussionmentioning
confidence: 99%
“…miRNAs play important roles in gene regulation and there is emerging evidence demonstrating their potential for use as biomarkers for AD and other diseases; it is likely therefore that miRNAs play significant roles in the pathogenic process underlying AD [55] [56]. Indeed, such roles have been suggested for miR-518e and miR-518a-3p in AD [51]. Similarly, miR-518c may also be a useful biomarker for Parkinson's disease [57] while miR-518b is dysregulated in esophageal carcinoma [58].…”
Section: Discussionmentioning
confidence: 99%